Sharps Technology, Inc.

NASDAQ: STSS · Healthcare · Medical - Instruments & Supplies

PublicHQ Melville, NY · SuffolkCIK 0001737995Reports USD

#1000 of 1,418 Healthcare companies by revenue

EA Score

33D

FH 42DQ 18GM —SS 41

v0.1 · 55/100 weight · provisional

↑ balance-sheet leverage, Altman-Z · ↓ disclosure history, operating margin

Methodology →

Revenue TTM

$2.5M

Rev growth YoY (TTM)

+1021.5%

Net income (FY)

-$282.5M

Employees

as of 2026-08-19

Market cap

$53.7M

as of 2026-08-19

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$204.1k$204.1k2025

Net income-$282.5M-$282.5M2025

Operating income-$269.7M-$269.7M2025

Total assets$269.1M$269.1M2025

Liabilities$4.7M$4.7M2025

Equity$264.4M$264.4M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Sharps Technology, Inc.’s revenue?

Sharps Technology, Inc. booked $204.1k in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -138400.0% net margin.

Peers · Healthcare

Brain Scientific Inc.——Anixa Biosciences, Inc.52D GlucoTrack, Inc.28D Lixte Biotechnology Holdings, Inc.40D Clene Inc.27D Windtree Therapeutics, Inc.——

Neighbors

Suffolk →

Henry Schein, Inc.$13.2B77B+MSC Industrial Direct Co., Inc.$3.8B74B Dime Community Bancshares, Inc.$19.9M57C ADI Global Distribution Inc.——Napco Security Technologies, Inc.$181.6M78B+Forward Industries, Inc.$18.2M35D

Key facts

CEOPaul K. Danner

SectorHealthcare

IndustryMedical - Instruments & Supplies

HeadquartersMelville, NY

ExchangeNASDAQ: STSS

Employees55

IPO date2022-04-14

Latest filings

DEF 14A2026-08-18 10-Q2026-08-07 8-K2026-07-17 8-K2026-06-01 8-K2026-05-29 10-Q2026-05-14 10-K2026-03-31 8-K2026-02-23

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.